acute graft versus host disease

Showing 1 - 25 of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Fecal Microbiota Transplantation Capsule
  • Placebo
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 6, 2023

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

Acute GVHD Trial (Itolizumab, Methylprednisolone)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Apr 10, 2023

Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

Recruiting
  • Acute Graft Versus Host Disease
  • MSCTC-0010 Dose Escalation
  • Kansas City, Kansas
    Kansas University Cancer Center
Jan 30, 2023

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Terminated
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Oct 18, 2022

Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota

Not yet recruiting
  • Acute Graft Versus Host Disease
  • +3 more
  • Fecal Microbiota Transplantation Capsule
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Acute GVHD Trial in Spain (Adult Allogeneic Mesenchymal cells from adipose tissue.)

Active, not recruiting
  • Acute Graft Versus Host Disease
  • Adult Allogeneic Mesenchymal cells from adipose tissue.
  • Pamplona, Navarra, Spain
  • +5 more
Feb 1, 2022

Acute GVHD Trial in United States (natalizumab, steroids)

Active, not recruiting
  • Acute Graft Versus Host Disease
  • Duarte, California
  • +11 more
Oct 15, 2021

Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

Active, not recruiting
  • Hematopoietic Stem Cell Transplantation
  • +4 more
  • Duarte, California
  • +3 more
Jul 19, 2021

Acute GVHD Trial in Houston (Exercise Intervention, Physical Performance Testing, Questionnaire Administration)

Terminated
  • Acute Graft Versus Host Disease
  • Exercise Intervention
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2021

GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))

Completed
  • Graft Versus Host Disease
  • +2 more
  • Autologous mesenchymal stromal cells (MSCs)
  • Atlanta, Georgia
    Children's Healthcare of Atlanta/Emory University
Mar 2, 2021

Acute GVHD Trial in Houston (pentostatin for injection)

Terminated
  • Acute Graft Versus Host Disease
  • pentostatin for injection
  • Houston, Texas
    MD Anderson Cancer Center
Oct 21, 2020

Acute GVHD Trial in Milwaukee (Tocilizumab)

Terminated
  • Acute Graft Versus Host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital/Medical College of Wisconsin-Clinical Cancer
Jan 30, 2020

Allogeneic Stem Cell Transplant, Acute GVHD, Acute Myeloid Leucaemia Trial in Leuven, Nijmegen (posaconazole)

Completed
  • Allogeneic Stem Cell Transplant
  • +3 more
  • Leuven, Belgium
  • +1 more
Dec 13, 2019

Markers of Inflammation in Hematopoietic Stem Cell Transplant

Completed
  • Acute Graft Versus Host Disease
    • Chicago, Illinois
      Lurie Children's Hospital
    Aug 28, 2019

    Acute GVHD, Intestinal GVHD Trial in Winston-Salem (Budesonide, Methylprednisolone Sodium Succinate)

    Withdrawn
    • Acute Graft Versus Host Disease
    • Intestinal Graft Versus Host Disease
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Jul 31, 2018

    Acute GVHD Trial in Stanford (AbGn-168H)

    Terminated
    • Acute Graft Versus Host Disease
    • AbGn-168H
    • Stanford, California
      Stanford University, School of Medicine
    Mar 28, 2017

    Acute GVHD Trial in Ann Arbor (Etanercept (Enbrel))

    Completed
    • Acute Graft Versus Host Disease
    • Etanercept (Enbrel)
    • Ann Arbor, Michigan
      University of Michigan
    Dec 4, 2015

    Acute GVHD Trial in Tampa (Tacrolimus (TAC), Methotrexate (MTX), Rapamycin (RAPA))

    Completed
    • Acute Graft Versus Host Disease
    • Tacrolimus (TAC)
    • +2 more
    • Tampa, Florida
      H.Lee Moffitt Cancer Center
    Jul 10, 2015

    Acute GVHD Trial in Jerusalem (Methylprednisolone (Intra-arterial continuous infusion of corticosteroids))

    Terminated
    • Acute Graft Versus Host Disease
    • Methylprednisolone (Intra-arterial continuous infusion of corticosteroids)
    • Jerusalem, Israel
      Hadassah Medical Organisation
    Apr 19, 2015

    Acute GVHD Trial in Houston (Recombinant Human Keratinocyte Growth Factor)

    Terminated
    • Acute Graft Versus Host Disease
    • Recombinant Human Keratinocyte Growth Factor
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 1, 2012

    PETCT for Diagnosing and Monitoring Acute GVHD

    Unknown status
    • Acute Graft Versus Host Disease
    • PETCT
    • Petah-Tiqva, Israel
      BMT unit, Rabin Medical Center, Beilinson Hospital
    May 9, 2012

    Acute GVHD Trial in Nijmegen, Rotterdam, Utrecht (IT-Combination)

    Withdrawn
    • Acute Graft Versus Host Disease
    • IT-Combination
    • Nijmegen, Netherlands
    • +2 more
    Apr 28, 2009